You have 9 free searches left this month | for more free features.

City

Clermont ferrand (1)

Copenhagen (1)

Glostrup (1)

Seongnam (1)

Condition

Ocular Hypertension (3)

Glaucoma (2)

Primary Open Angle Glaucoma (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 4 (3)

Sponsor

CHA University (1)

Laboratoires Thea (1)

Rigshospitalet, Denmark (1)

Collaborator

Laboratoires Thea (1)

Samil Pharmaceutical Co., Ltd. (1)

Intervention

monoprost (3)

xalatan (2)

lumigan 0.01% (1)

lumigan 0.03% unit dose (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

monoprost

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glaucoma, Ocular Hypertension Trial in Seongnam (Monoprost, Xalatan)

Completed

Glaucoma
Ocular Hypertension

Monoprost
Xalatan

Seongnam, Bundang-gu, Korea, Republic of

CHA University Bundang Medical Center

Feb 4, 2021

Glaucoma, Ocular Hypertension Trial in Glostrup, Copenhagen (Xalatan, Monoprost)

Not yet recruiting

Glaucoma
Ocular Hypertension

Xalatan
Monoprost

Glostrup, Danmark, Denmark
+1 more

Jun 30, 2021

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Clermont ferrand (Monoprost, Lumigan 0.01%, Lumigan 0.03% Unit Dose)

Completed

Has Results

Primary Open Angle Glaucoma
Ocular Hypertension

Monoprost
+2 more

Clermont ferrand, France

Laboratoires Théa

Mar 20, 2020